Kimberly Rose Podhorniak, | |
11685 Crossroads Cir, Middle River, MD 21220-3067 | |
(410) 282-8500 | |
Not Available |
Full Name | Kimberly Rose Podhorniak |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 11685 Crossroads Cir, Middle River, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235861881 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 20832 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kimberly Rose Podhorniak, 9814 Perryland Ct, Perry Hall, MD 21128-4515 Ph: (410) 698-5401 | Kimberly Rose Podhorniak, 11685 Crossroads Cir, Middle River, MD 21220-3067 Ph: (410) 282-8500 |
News Archive
Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.
Santarus, Inc., a specialty biopharmaceutical company, today announced that positive data from two investigator-initiated studies with ZEGERIDĀ® (omeprazole/sodium bicarbonate) will be presented in poster sessions at the American College of Gastroenterology (ACG) 2009 Annual Scientific Meeting taking place in San Diego. These studies were supported by grants from Santarus.
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
› Verified 1 days ago
Rachel N Thierry, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 38 Cutter Cove Ct, Middle River, MD 21220 Phone: 410-841-8453 | |
Sarah Hardy, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 47 S Hawthorne Rd, Middle River, MD 21220 Phone: 419-509-5482 | |
Marissa L Smothers, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3901 Hunt Harbor Rd, Middle River, MD 21220 Phone: 410-627-3483 |